|
||
---|---|---|
UniProt ID |
Q06186 |
|
Entry Name |
HBEGF_MOUSE |
|
Protein Name |
Proheparin-binding EGF-like growth factor [Cleaved into: Heparin-binding EGF-like growth factor |
|
Primary Gene Name |
Hbegf |
|
Organism |
Mus musculus (Mouse) |
|
Molecular Function |
Growth factor |
|
Membrane Location |
Secreted |
|
---|
Substrate Name | HB-EGF | |
Cell Type | cardiomyocytes | |
Substrate Description | ||
Substrate Function Category | disease | |
Substrate Function Subtype | Disease: cardiac hypertrophy | |
Sheddase | ADAM12 | |
Shedding-related Disease | cardiac hypertrophy | |
Short Summary of Papers | shedding of (HB-EGF) and subsequent transactivation of the EGFR when cardiomyocytes were stimulated by GPCR agonists | |
Cleavage Information | NONE | |
PMID | 11786904 |
Substrate Name | HB-EGF | |
Cell Type | keratinocyte cell, human corneal epithelial (THCE) cells | |
Substrate Description | Cutaneous Wound Healing (tissue repair) | |
Substrate Function Category | growth factor & growth hormone | |
Substrate Function Subtype | growth factor (EGFR) | |
Sheddase | ADAM9, ADAM10, ADAM12, ADAM17 | |
Shedding-related Disease | growth factor (EGFR) | |
Short Summary of Papers | wound-Induced HB-EGF Ectodomain Shedding and EGFR Activation in Corneal Epithelial Cells | |
Cleavage Information | NONE | |
PMID | 11038170 14985295 |
Substrate Name | HB-EGF | |
Cell Type | SH-SY5Y, Namalwa, CHO cells | |
Substrate Description | EGFR signaling, various signals in cell proliferation, survival and migration | |
Substrate Function Category | growth factor & growth hormone | |
Substrate Function Subtype | growth factor (EGFR) | |
Sheddase | MMP-7, ADAM17 | |
Shedding-related Disease | growth factor (EGFR) | |
Short Summary of Papers | conversion from juxtacrine to a paracrine/autocrine growth factor, soluble agonist of EGFR and ErbB4 | |
Cleavage Information | NONE | |
PMID | 11825873 18951988 |
|
---|
|
||
---|---|---|
|
Start | End |
|
24 | 160 |
|
161 | 184 |
|
||||||||
---|---|---|---|---|---|---|---|---|
Database | CutSeq | Mapped Position | Protease | Type | Evidence | PMID | ||
MEROPS | RRGL*AAAT | 33 | ADAM17 peptidase | physiologically relevant | NONE | 15066986    | ||
MEROPS | PSKE*RNGK | 89 | ADAM10 peptidase | physiologically relevant | NONE | 15066986    | ||
PMAP | PSKE*RNGK | 89 | ADAM10 peptidase | This_entry_is_based_on_an_experiment. | 15066986    | |||
MEROPS | KKGK*GLGK | 99 | ADAM10 peptidase | physiologically relevant | NONE | 15066986    | ||
MEROPS | LTLP*VENP | 149 | ADAM17 peptidase | physiologically relevant | NONE | 15066986    | ||
PMAP | LTLP*VENP | 149 | ADAM17 peptidase | This_entry_is_based_on_an_experiment. | N-terminal sequencing | 15066986    | ||
MEROPS | NPLY*TYDH | 155 | ADAM10 peptidase | physiologically relevant | NONE | 15066986    | ||
PMAP | No_information | ADAM17 peptidase | This_entry_is_based_on_an_experiment. | 14993236    |